In today’s recent session, 0.88 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have been traded, and its beta is 2.24. Most recently the company’s share price was $9.49, and it changed around $1.69 or 21.70% from the last close, which brings the market valuation of the company to $53.07M. TNXP at last check was trading at a discount to its 52-week high of $1216.00, offering almost -12713.49% off that amount. The share price’s 52-week low was $6.76, which indicates that the recent value has risen by an impressive 28.77% since then.
Tonix Pharmaceuticals Holding Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended TNXP as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Tonix Pharmaceuticals Holding Corp is expected to report earnings per share of 0 for the current quarter.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Instantly TNXP has been showing a green trend so far today with a performance of 21.70% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 10.37 on recent trading dayincreased the stock’s daily price by 8.49%. The company’s shares are currently down -71.22% year-to-date, but still up 12.60% over the last five days. On the other hand, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is -51.30% down in the 30-day period.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
The year-over-year growth rate is expected to be 66.71%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 3.35M in revenue for the current quarter. 1 analysts expect Tonix Pharmaceuticals Holding Corp to make 4.2M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 3.78M and 2.48M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -11.35%. Forecasts for the next quarter put sales growth at 69.22%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 79.31%. Tonix Pharmaceuticals Holding Corp earnings are expected to increase by 95.88% in 2025, but the outlook is positive 78.59% per year for the next five years.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 10.45 shares worth $98125.0, making up 0.19% of all outstanding shares. On the other hand, Fidelity Total Market Index Fund held roughly 4.03 shares worth around $37869.0, which represents about 0.07% of the total shares outstanding.
